| Issue |
Section |
Title |
File |
| Vol 20, No 2 (2022) |
Articles |
Soluble forms of programmable cell death receptor sPD-L and ligand sPD-L1, as well as some biochemical and hematological indicators in the blood of COVID-19 diseased |
|
| Vol 20, No 3 (2022) |
Articles |
Progastrin-releasing peptide (proGRP) and neuron specific enolase (NSE) in survival prognosis in patients with small cell lung cancer |
|
| Vol 20, No 4 (2022) |
Articles |
Galectin-3, haptoglobin and proangiogenic factors in gastric cancer |
|
| Vol 20, No 6 (2022) |
Original research |
Comparative study of the soluble forms of immune checkpoint proteins VISTA, PD-1, PD-l1, and bone homeostasis regulator RANKL in bone tumor patients |
|
| Vol 21, No 5 (2023) |
Reviews |
New long non-coding RNAs in lung cancer tumorigenesis |
|
| Vol 22, No 5 (2024) |
Original research |
Comparative analysis of the diagnostic accuracy of endostatin and vegf serum levels in patients with bone sarcomas |
|
| Vol 22, No 6 (2024) |
Reviews |
The role of soluble immune checkpoint molecules in hematologic malignancies (review) |
|
